These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25451849)

  • 41. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin.
    Depré M; Van Hecken A; Oeyen M; De Lepeleire I; Laethem T; Rothenberg P; Petty KJ; Majumdar A; Crumley T; Panebianco D; Bergman A; de Hoon JN
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):341-6. PubMed ID: 15983826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and warfarin in healthy volunteers.
    Macha S; Rose P; Mattheus M; Pinnetti S; Woerle HJ
    Diabetes Obes Metab; 2013 Apr; 15(4):316-23. PubMed ID: 23094794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction between Warfarin and Linezolid in Patients with Left Ventricular Assist System in Japan.
    Kinoshita S; Wada K; Matsuda S; Kuwahara T; Sunami H; Sato T; Seguchi O; Yanase M; Nakatani T; Takada M
    Intern Med; 2016; 55(7):719-24. PubMed ID: 27041154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of etoricoxib on the pharmacodynamics and pharmacokinetics of warfarin.
    Schwartz JI; Agrawal NG; Hartford AH; Cote J; Hunt TL; Verbesselt R; Eckols DR; Gottesdiener KM
    J Clin Pharmacol; 2007 May; 47(5):620-7. PubMed ID: 17442687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.
    Tashiro M; Takazono T; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Kakeya H; Ando T; Ogawa K; Kishi K; Tokimatsu I; Hayashi Y; Fujiuchi S; Yanagihara K; Miyazaki Y; Ichihara K; Mukae H; Kohno S; Izumikawa K
    Clin Infect Dis; 2020 Feb; 70(5):835-842. PubMed ID: 30959519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An evaluation of the potential drug interaction between warfarin and levothyroxine.
    Wood MD; Delate T; Clark M; Clark N; Horn JR; Witt DM
    J Thromb Haemost; 2014 Aug; 12(8):1313-9. PubMed ID: 24913218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin.
    Sheth SB; DiCicco RA; Hursting MJ; Montague T; Jorkasky DK
    Thromb Haemost; 2001 Mar; 85(3):435-40. PubMed ID: 11307810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acetaminophen and other risk factors for excessive warfarin anticoagulation.
    Hylek EM; Heiman H; Skates SJ; Sheehan MA; Singer DE
    JAMA; 1998 Mar; 279(9):657-62. PubMed ID: 9496982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
    Modi NB; Kell S; Simon M; Vargas R
    J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ifosfamide and etoposide chemotherapy may interact with warfarin, enhancing the warfarin induced anticoagulant response.
    Okada N; Watanabe H; Kagami S; Ishizawa K
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):58-61. PubMed ID: 26587904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Warfarin-cranberry juice interaction.
    Hamann GL; Campbell JD; George CM
    Ann Pharmacother; 2011 Mar; 45(3):e17. PubMed ID: 21364039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients.
    Lawrie AS; Hills J; Longair I; Green L; Gardiner C; Machin SJ; Cohen H
    Thromb Res; 2012 Jul; 130(1):110-4. PubMed ID: 21937093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
    Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ
    Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic monitoring of warfarin: the appropriate response marker.
    Costa IM; Soares PJ; Afonso M; Ratado P; Lanaot JM; Falcão AC
    J Pharm Pharmacol; 2000 Nov; 52(11):1405-10. PubMed ID: 11186249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential drug interaction between warfarin and linezolid.
    Sakai Y; Naito T; Arima C; Miura M; Qin L; Hidaka H; Masunaga K; Kakuma T; Watanabe H
    Intern Med; 2015; 54(5):459-64. PubMed ID: 25758070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin.
    Schwartz JI; Dunbar S; Yuan J; Li S; Gipson A; Rosko K; Johnson-Levonas AO; Lasseter KC; Addy C; Stoch AS; Wagner JA
    Adv Ther; 2008 Nov; 25(11):1175-90. PubMed ID: 18989636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An algorithm for managing warfarin resistance.
    Osinbowale O; Al Malki M; Schade A; Bartholomew JR
    Cleve Clin J Med; 2009 Dec; 76(12):724-30. PubMed ID: 19952297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range.
    Schulman S; Melinyshyn A; Ennis D; Rudd-Scott L
    Thromb Res; 2010 May; 125(5):393-7. PubMed ID: 19640572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.